“Differentiation Syndrome and Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated with All-Trans Retinoic Acid” (2023) Annals of Leukemia Research, 4(1), pp. 7–12. doi:10.5281/zenodo.22213697.